Management of Chronic Eczema
The most effective approach to chronic eczema management involves a stepwise treatment strategy starting with liberal emollient use and topical corticosteroids as first-line therapy, progressing to topical calcineurin inhibitors, phototherapy, and systemic immunosuppressants for refractory cases. 1
First-Line Treatment
Emollient Therapy
- Apply emollients 3-8 times daily, even when skin appears normal, as the foundation of eczema management 1
- Use ointments rather than creams for dry, irritable rashes as they provide better barrier function
- Apply at least once daily to the entire body, more frequently on affected areas
- Avoid alcohol-containing products which can worsen dryness
Topical Corticosteroids
- Use mild potency topical corticosteroids (e.g., 1% hydrocortisone) for mild flares and in sensitive areas 1
- Apply twice daily for short periods (7-14 days) to treat flares
- For moderate flares not responding to mild steroids, use medium potency steroids like 0.05% clobetasone butyrate for short periods
- Return to mild steroid or emollient-only therapy after resolution
- Consider "weekend therapy" with mild steroids to prevent relapses 1
Infection Management
- Monitor for signs of secondary infection (increased redness, weeping, crusting)
- Use antiseptics on erosive lesions (e.g., aqueous chlorhexidine 0.05%)
- Consider bleach baths with 0.005% sodium hypochlorite twice weekly to prevent infections
- Use systemic antibiotics only when there is clear evidence of infection 1
Second-Line Treatment
Topical Calcineurin Inhibitors
- Pimecrolimus cream 1% (Elidel) is indicated for patients age 2 years and older who have not responded to other prescription medicines 2
- Apply a thin layer only to affected areas twice daily
- Use for short periods, and if needed, treatment may be repeated with breaks in between
- Avoid continuous long-term use due to potential safety concerns 2
- Do not use in children under 2 years of age
Phototherapy
- Consider for cases not responding to topical treatments 1
- Options include narrow-band UVB, broadband UVB, and UVA1
- PUVA therapy can be particularly effective for hand eczema, with significant improvement in 81-86% of patients 1
- Be aware of potential risks including premature skin aging and cutaneous malignancies, particularly with PUVA 3
Third-Line Treatment
Systemic Therapy
- Systemic corticosteroids have a limited but definite role in tiding occasional patients with severe atopic eczema 3
- Should not be considered for maintenance treatment until all other options have been explored
- For moderate to severe cases, dupilumab has shown the highest efficacy among biological treatments 4
- Other systemic options include:
Special Considerations
Allergen Avoidance
- Consider food allergies in infants with severe eczema, particularly if eczema persists despite optimized management 1
- The role of house dust mites in atopic eczema is not strongly supported by evidence for eradication benefits 3
- Identify and eliminate triggering substances and avoid irritant clothing 1
Psychological Support
- Patient support groups and contact with other patients or parents can help reduce feelings of helplessness and isolation 3
- Consider cognitive behavioral techniques such as relaxation therapy
- Access to a clinical psychologist is recommended for severe cases 3
Common Pitfalls
- "Steroid phobia" often leads to insufficient treatment and prolonged suffering 1
- Using potent steroids unnecessarily increases the risk of side effects
- Applying topical corticosteroids to the face, diaper area, and skin folds should be avoided unless specifically directed 1
- Deterioration in previously stable eczema may indicate secondary infection or contact dermatitis 1
When to Refer to a Specialist
- Diagnostic doubt
- Failure to respond to maintenance treatment with appropriate topical steroids
- When second-line treatment is required
- When specialist opinion would be valuable in counseling patients and family 3
By following this evidence-based approach to chronic eczema management, most patients can achieve significant improvement in their condition and quality of life.